Xylem Faces Earnings With Targets Reset and Options Turning Bullish

Xylem makes water technology equipment and software for utilities, industrial customers, and municipalities. It reports third-quarter results on October 27 with its shares at $108.74, up 4.5% over the past week, well clear of the median move among its closest peers, which was roughly flat to down.

The options market tells a notably more constructive story than it did a week ago. The put/call ratio has dropped to 0.78, more than a standard deviation below its 20-day average of 0.87. That shift suggests traders have rotated away from downside protection and toward call exposure in the days immediately before the print. The move stands in contrast to the cautious tone that defined positioning through most of October, when the PCR sat above 0.93 for several consecutive sessions. Borrow conditions remain relaxed throughout: availability is at 653%, meaning there are roughly six and a half shares available to lend for every share already borrowed, and the cost to borrow is 0.46%, near the low end of its recent range.

Short interest at 4.6% of the free float is modest enough that it is not driving the narrative. The position has grown about 10% over the past month, but with availability this loose and borrowing costs this low, there is no squeeze dynamic in place.

The central tension heading into the print is an analyst community that has collectively repriced its expectations but not its ratings. Since early October, JP Morgan lowered its target to $118 from $137, while Citigroup, Barclays, RBC Capital, Oppenheimer, Mizuho, and UBS all trimmed their own numbers by anywhere from $8 to $29. The consensus mean now sits at roughly $142, against a stock price of $108. That gap reflects genuine disagreement about timing rather than direction: most firms still carry positive ratings, but the scale of the cuts signals reduced confidence that Xylem can deliver the margin expansion and earnings growth needed to close it quickly. Management's own 2026 EPS guidance was cut to $5.67, and the P/E on that figure at the current price is about 19x. Bulls point to major contract wins including an $850 million deal with Dow and the Miami-Dade advanced metering project, and to structural tailwinds from utility outsourcing and water infrastructure spending. Bears argue that execution risk is real, that China weakness and project timing delays are compressing near-term results, and that regulatory catalysts such as the Advancing Water Reuse Act are unlikely to provide any lift until 2027 at the earliest.

The October 27 report is therefore less a test of whether Xylem's long-term water infrastructure thesis is intact, and more a test of whether management can demonstrate credible progress on margins and order momentum against a Street that has spent the past two weeks resetting its expectations downward.